High levels of factor VIII and risk of extra-hepatic portal vein obstruction

Journal of Hepatology

Volumn 50, Issue 5, 2009, Pages 916-922

  Martinelli, Ida ^a   Primignani, Massimo ^a   Aghemo, Alessio ^a   Reati, Raffaella ^a   Bucciarelli, Paolo ^a   Fabris, Federica ^a   Battaglioli, Tullia ^a   Dell'Era, Alessandra ^a   Mannucci, Pier Mannuccio ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Coagulation; Factor VIII; Liver disease; Portal vein thrombosis; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EXTRAHEPATIC PORTAL VEIN OBSTRUCTION; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR;

ACUTE-PHASE REACTION; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FACTOR VIII; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL VEIN; RISK FACTORS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 64749112961     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.12.020     Document Type: Article

References (34)

1. Sobhonslidsuk A., and Reddy K.R. Portal vein thrombosis: a concise review. Am J Gastroenterol 97 (2002) 535-541
2. Valla D., Casadevall N., Huisse M.G., Tulliez M., Grange J.D., Muller O., et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology 94 (1988) 1063-1069
3. Valla D.C., and Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 32 (2000) 865-871
4. Denninger M.H., Chait Y., Casadevall N., Hillaire S., Guillin M.C., Bezeaud A., et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31 (2000) 587-591
5. Primignani M., Martinelli I., Bucciarelli P., Battaglioli T., Reati R., Fabris F., et al. Risk factors for thrombophilia in extra-hepatic portal vein obstruction. Hepatology 41 (2005) 603-608
6. Mahmoud A.E.A., Elias E., Beauchamp N., and Wilde J.T. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 40 (1997) 798-800
7. Chamouard P., Pencreach E., Maloisel F., Grunebaum L., Ardizzone J.F., Meyer A., et al. Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. Gastroenterology 116 (1999) 144-148
8. Janssen H.L.A., Meinardi J.R., Vleggaar F.P., van Uum S.H.M., Haagsma E.B., van der Meer F.J.M., et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 96 (2000) 2364-2367
9. Madonna P., De Stefano V., Coppola A., Cerbone A.M., and Di Minno G. G20210A prothrombin gene mutation and other thrombophilic polymorphisms in patients with portal or hepatic venous thrombosis. Gastroenterology 120 (2001) 1059-1067
10. Mohanty A., Shetty S., Ghosh K., Pawar A., and Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari Syndrome: a study from western India. Hepatology 34 (2001) 666-670
11. Dentali F., Galli M., Gianni M., and Ageno W. Inherited thrombophilic abnormalities and risk of portal vein obstruction. Thromb Haemostas 99 (2008) 675-682
12. Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 86 (2001) 395-403
13. Koster T., Blann A.D., Briet E., Vandenbroucke J.P., and Rosendaal F.R. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345 (1995) 152-155
14. Kraaijenhagen R.A., in't Anker P.S., Koopman M.M.W., Reitsma P.H., Prins M.H., van den Ende A., et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 83 (2000) 5-9
15. O'Donnell J., Tuddenham E.G.D., Manning R., Kemball-Cook G., Johnson D., and Laffan M. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 77 (1997) 825-828
16. O'Donnell J., Mumford A.D., Manning R.A., and Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost 83 (2000) 10-13
17. Koshy A., and Jeyakumari M. High factor VIII level is associated with idiopathic portal vein thrombosis in South India. Am J Med 120 (2007) 552 e9-e11
18. Shah S.R., DasGupta A., Sharma A., Joshi A., Desai D., Abraham P., et al. Thrombophilic conditions in non-cirrhotic portal vein thrombosis. Indian J Gastroenterol 24 (2005) 205-210
19. Fimognari F.L., De Santis A., Piccheri C., Moscatelli R., Gigliotti F., Vestri A., et al. Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. J Lab Clin Med 146 (2005) 238-243
20. Brandenburg V.M., Frank R.D., Wasmuth H.E., and Gartung C. Elevated levels of factor VIII:C as possible risk factor for portal, splenic, and mesenteric vein thrombosis. Gastroenterology 120 (2001) 1563-1564
21. Pugh R.N.H., Murray-Lyon I.M., Dawson J.L., Pietroni M.G., and Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
22. Frezzato M., Tosetto A., and Rodeghiero F. validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 143 (1996) 1257-1265
23. Mannucci P.M., and Tripodi A. Factor VIII clotting activity. In: Jespersen J., Bertina R.M., and Haverkate F. (Eds). Laboratory techniques in thrombosis. A manual (1999), Kluwer Academic Publishers, Dordrecht 107-113
24. Bertina R.M., Koeleman B.P.C., Koster T., Rosendaal F.R., Dirven R.J., De Ronde H., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
25. Poort S.R., Rosendaal F.R., Reitsma P.H., and Bertina R.M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 (1996) 3698-3703
26. Tripodi A. Review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia. Sem Thromb Haemost 31 (2005) 25-32
27. Brandt J.T., Triplett D.A., Alving B., and Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 74 (1995) 1185-1190
28. Zighetti M.L., Cattaneo M., Falcon C.R., Lombardi R., Harari S., Savonitto S., et al. Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension. Thromb Res 85 (1997) 279-282
29. Lowe G.D.O., Rumley A., Woodward M., Morrison C.E., Philippou H., Lane D.A., et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative ranges by age, sex and hormone use. Br J Haematol 97 (1997) 775-784
30. Tripodi A., Salerno F., Chantarangkul V., Clerici M., Cazzaniga M., Primignani M., et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 41 (2005) 553-558
31. Rosenberg R.D., and Aird W.C. Vascular-bed-specific hemostasis and hypercoagulable states. N Eng J Med 340 (1999) 1555-1564
32. Psaty B.M., Smith N.L., Lemaitre R.N., Vos H.L., Keckbert S.R., LaCroix A.Z., et al. Hormone replacement therapy, prothrombotic mutation, and the risk of incident nonfatal myocardial infarction in postmenopausal women. JAMA 285 (2000) 906-913
33. Reny J.L., Alhenc-Gelas M., Fontana P., Bissery A., Julia P.L., Fiessinger J.N., et al. The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case control study. J Thromb Haemost 2 (2004) 1334-1340
34. Amitrano L., Brancaccio V., Guardascione M.A., Margaglione M., Iannacone L., D'Andrea G., et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 31 (2000) 354-358